ENDRA Life Sciences Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ENDRA Life Sciences Inc. on June 15, 2021, covering events occurring on June 9, 2021, and June 11, 2021. The company is an emerging growth company incorporated in Delaware, with its principal executive offices in Ann Arbor, Michigan. The report addresses significant changes in executive leadership under Item 5.02.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance metrics.
Material Changes
- Departure of CFO: David Wells resigned as Chief Financial Officer, effective June 18, 2021. The resignation is not related to any disagreement regarding the company's operations, policies, or practices.
- Appointment of Principal Financial Officer: Irina Pestrikova was appointed as Senior Director, Finance, effective upon Mr. Wells' resignation. She will serve as the company's principal financial officer.
- Compensation Arrangement: Ms. Pestrikova will receive an annual salary of $160,000 and 75,000 stock options vesting in three equal annual installments.
Outlook, Risks, and Management Commentary
Mr. Wells may provide consulting services to the company post-departure to assist with transitional matters. The filing states there are no family relationships between Ms. Pestrikova and any director or executive officer, and she holds no material interest in transactions requiring disclosure under Item 404(a). The company announced the appointment via a press release dated June 15, 2021.
Key Facts for Investor Verification
- Confirm the effective date of the CFO transition (June 18, 2021) and the interim financial reporting structure.
- Verify the vesting schedule and terms of the 75,000 stock options granted to the new Principal Financial Officer.
- Review the attached press release (Exhibit 99.1) for additional context on the leadership transition.
- Monitor future filings for the appointment of a permanent Chief Financial Officer if Ms. Pestrikova's role remains interim.